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PENYEDIAAN DAN PENCIRIAN FILEM KOLAGEN TERCANGKUK POLl 
(DIMETIL SILOKSANA) TERUBAHSUAI UNTUK APLIKASI PENGGANTI 
KULIT 
ABSTRAK 
Poli(dimetil siloxana) (PDMS) filem yang berpusat diubah dengan menggunakan 
hidrogel dan kolagen untuk menghasilkan pelbagai jenis pengganti kulit. PHEMA 
(poli(hidroksietil metakrilat)) dan PAA (poli(asid akrilik)) digunakan melalui kaedah 
jujukan lPN (interpenetrating polymer networks) dan kaedah campuran bagi 
menghasilkan suatu kumpulan fungsi yang sesuai untuk menempatkan kologen pada 
lapisan luar PDMS, dalam usaha meningkatkan kebioserasian mereka. Kolagen Genis 
I) dipautkan secara kovalen pada saput yang telah diubah suai dengan menggunakan 
kopel agen untuk mengaktifkan kumpulan hidroksil pada PHEMA dan karboksil 
pada P AA. Kolagen bertindak balas dengan kumpulan teraktif untuk membentuk 
lapisan protein yang terpaut secara kovalen. Sifat permukaan saput yang tidak dubah 
suai dan yang diubah suai dapat dilihat melalui ATR-FTIR (pantulan jumlah 
perosotan - spektroskopi inframerah jelmaan Fourier), XPS (spektroskopi 
fotoelektron sinar X ) dan SEM (mikroskopi imbasan electron). DMTA (analisis 
haba mekanikal dinamik), ujian regangan dan ukuran kekuatan koyak digunakan 
untuk menyelidik sifat fizikal dan mekanikal sampel yang diubah suai. Ukuran 
jerapan air dan sudut sentuh air dijalankan pada sampel untuk menilai 
kebolehbasahan permukaan. Berdasarkan teknik pencirian yang digunakan, didapati 
bahawa sampel daripada kedua-dua teknik (lPN dan kaedah campuran) lebih 
hidrofilik dibandingkan dengan kandungan hidrogel. Cantuman kolagen pada 
permukaan terbukti melalui ATR-FTIR dan XPS. Mikrograf SEM bagi keratan 
XIV 
rentas menunjukk:an wujudnya dua sistem fasa pada rangk:aian kedua dalam kaedah 
IPN yang bertambah dengan meningk:atnya gabungan PHEMA dan P AA. Sifat 
mekanikal PDMS yang diubah suai dengan PHEMA tidak berubah sehingga 30% 
berat daripada kandungan PHEMA, dibandingk:an dengan sampel tulen. W alau 
bagaimanapun, kesan pengukuhan diperhatikan pada sampel PDMS/P AA IPN 
sehingga hampir 25% berat P AA. Keputusan DMTA menunjukk:an terdapat dua T gS 
dalam sistem IPN, dan sampel ini adalah system polimer fasa 2. Sampel campuran 
juga merupakan sistem dwikomponen. Sebaliknya, di dalam PDMS dan hidrogel, 
ia adahth fasa yang selanjar dan terserak. Penilaian kebioserasian bagi PDMS yang 
tidak diubah suai dan diubah suai diteliti dalam penilaian in vitro melalui 
pengkulturan sel fibroblas (L929) pada permukaan mereka. Sampel PDMS yang 
diubah suai lebih serasi dengan sel fibroblas dibandingk:an dengan sampel tulen. Ia 
juga tidak menunjukk:an sebarang kesitotoksikan. Permukaan berkalogen secara 
signifikan menunjukk:an rekatan dan pertumbuhansel dan pertumbuhan berbanding 
dengan sampel lPN dan sampel campuran, yang kekurangan kolagen. 
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PREPARATION AND CHARACTERIZATION OF COLLAGEN GRAFTED 
POLY(DIMETHYL SILOXANE) MODIFIED FILMS FOR SKIN 
SUBSTITUTE APPLICATIONS 
ABSTRACT 
Poly(dimethyl siloxane) (PDMS) based films were modified using hydrogels and 
collagen to produce different types of skin substitute. Poly(hydroxyethyl 
methacrylate) (PHEMA) and poly(acrylic acid)(PAA) were used via sequential 
method of interpenetrating polymer networks (IPNs) and blending methods to create 
suitable functional groups to immobilize collagen in outer layer of PDMS in order to 
enhance their biocompatibility. Collagen (type I) was covalently linked onto the 
modified films via coupling agent to activate the hydroxyl groups ofPHEMA and the 
carboxylic groups of P AA. Collagen reacted with the activated groups to obtain 
covalently linked protein layers. The surface properties of unmodified and modified 
films were characterised by attenuated total reflectance Fourier transform infrared 
spectroscopy (ATR-FTIR), X-ray photoelectron spectroscopy (XPS) and scanning 
electron microscopy (SEM). Dynamic mechanical thermal analysis (DMTA), tensile 
testing and tear strength measurement were used to investigate the physical and 
mechanical properties of the modified samples. Water adsorption and water contact 
angle measurements were performed on the samples in order to evaluate their surface 
wettability. The aforementioned characterisation techniques indicated that both IPNs 
and blends samples exhibited more hydrophilicity according to hydrogels content. 
Grafting of collagen on the surfaces were confirmed using ATR-FTIR and XPS. The 
SEM micrographs of the cross section demonstrated the appearance of two-phase 
system that area phases of the second network in lPN method increased with 
xvi 
increasing incorporation of PHEMA and P AA. The mechanical properties of 
modified PDMS with PHEMA did not change considerably up to 30 wt«'/o of 
PHEMA content in comparison to pure samples. However, a reinforcing effect was 
observed at PDMS/P AA IPNs samples up to approximately 25 wt% P AA. The 
DMTA results indicated that there are two T8s in the lPN systems and these samples 
are two-phase polymeric systems. The blends samples also are a bicomponent system, 
wherein the PDMS and hydrogels are the continuous and dispersed phases, 
respectively. The biocompatibility evaluations of unmodified and modified PDMS 
were investigated in in-vitro evaluation by culturing fibroblast cells (L929) on their 
surfaces. The modified PDMS samples were more compatible with fibroblast cells 
than the pure samples and did not show any cytotoxicity. The collagen grafted 
surfaces showed significant cell adhesion and growth in comparison with IPNs and 
blends samples which were lack of collagen. 
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CHAPTER! 
INTRODUCTION 
1.1 Polymeric biomaterials 
The development of polymeric biomaterials can be considered as an evo-
lutionary process. Reports on the applications of natural polymers as biomaterials 
date back thousands of years (Barbucci, 2002). However, the application of synthetic 
polymers to medicine is more or less a recent phenomenon. The use of polymeric 
biomaterials as we know them today started in the 1940s during the Second World 
War (Castner and Ratner, 2002). Recent advances in polymeric biomaterials have 
been focused towards solving problems of patients who have suffered tissue, organ 
loss and defects (Hu et al., 2003). 
Many natural and synthetic or their hybrid matrices have been developed to 
cover wound sites, replace lost tissue functions and support cell growth. For example, 
aliphatic polyesters such as poly(lactic acid) are versatile biomaterials due to their 
biodegradability and biocompatibility (Moon et al., 2000; Moon et al., 2001; Shinoda 
et al., 2003). Synthetic matrices have many advantages because their molecular 
design, mechanical and physical properties can be controlled and they can be 
manufactured on any scale. However, the usage of synthetic biomaterial is still 
limited because of poor cell attachment/growth, adsorption of proteins and induction 
of thrombogenesis on the surface. Furthermore, some of the synthetic polymers are 
difficult to modify due to the lack of sufficient reactive functional groups. On the 
other hand, natural substrates such as proteins have been extensively used because of 
excellent biocompatibility and bioactivity (Lee et al., 2001). 
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Many attempts for establishing novel biomedical applications have been 
studied by modification or combination of natural polymers including proteins e.g. 
collagen (Wang et al., 2003; Wang et al., 2006), cellulose (Ishihara et al., 1992), 
alginate (Knill et al., 2004; Lopez et al., 1997), chitin, and chitosan (Mori et al., 
1997). The use of biomaterials to interface with living systems, such as fluids, cells, 
and tissues of the body, has played an increasingly important role in medical 
applications. In particular, synthetic and natural polymers, metals, ceramics, 
composites, and tissue-derived materials have been applied in medicine and 
pharmaceutics. These materials can be used in the permanent replacement of 
defective organs and tissues, temporary support of defective or normal organs, 
storage and purification of blood, and also control of drug delivery. 
The minimum requirements for biomaterials are: non-toxicity, functionality, 
sterilisability, and biocompatibility. Among these requirements, biocompatibility is 
essential issue for biomedical applications (Ratner et al., 2004). Polymeric 
biomaterials are relatively easy to manufacture into products with various shapes, at 
reasonable cost, and with desirable mechanical and physical properties. However, 
one of the major factors limiting the use of these materials is their biocompatibility. 
A challenge is thus to enhance their biocompatibility, at least at the interface with 
host tissues and fluids. Depending on the intended medical application, all 
biomaterials are evaluated in terms of biocompatibility. In particular, the design of 
biocompatible synthetic surfaces that are able to control the interaction between a 
living system and an implanted material remains a major theme for biomedical 
applications. The effects of the chemical structure and the surface properties of 
polymer biomaterials that influence their biocompatibility include: i) the interfacial 
free energy, ii) balance between the hydrophilicity and the hydrophobicity on the 
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surface, iii) the chemical structure and functional groups, iv) the type and the density 
of surface charges, v) the molecular weight of the polymer, vi) conformational 
flexibility of the polymer, and (vii) surface topography and roughness (Xiong and 
Bokor, 2004). 
1.2 Biocompatibility 
The ability to replace or augment damaged organs, blood vessels, tissues, 
totally or in part, has improved both the quality and the length oflife of many people. 
The decline in surgical risk during recent decades has encouraged the development 
of more complex procedures for prosthetic implantation. The availability and 
suitability of traditional natural (autogenous, homogenous) prosthetic element is 
severely limited ,as a result, strong interest has been focused on the use of synthetic 
materials which would provide an asymptomatic, long term function within the body 
or in contact with body fluid. 
A biomaterial is defined as a material intended to interface with biological 
systems to evaluate, treat, augment or replace any tissue, organ or function of the 
body (Williams, 1999). The study of biomaterials involves investigations into their 
relevant characteristics, i.e., their mechanical, thermal, electrical and especially 
surface properties, for the surface is in contact with living tissues. Thus, the study of 
these surfaces is crucial to determine their biological behaviour and to evaluate their 
hydrophobic or hydrophilic character (Ratner et al., 2004). Biomaterials are used to 
manufacture prostheses, implants, and surgical instruments. They can be natural such 
as collagen, cellulose or synthetic such as metals, ceramics, polymers, and others. 
Employed in plastic and reconstructive surgery, used to make the tools needed to 
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examine the human body, and expected to improve the deficiency of an organ, 
biomaterials must be biologically compatible with the organism. Many biomaterials 
have been used due to their bioinertness or bioactivity (Park et al., 1995; Hench, 
1998; Galletti, 1995) depending on the specific aim, but also on availability. At 
present, research on biomaterials science is combining biomaterials, biotechnology 
and molecular biology, in order to have biomaterials with a specific biological 
functionality (Wang et al., 2006; Aguilar et al., 2002; Patrick Jr et al., 1998; Piskin, 
1997). 
The essential prerequisite to qualify a material as a biomaterial is that it 
should be biocompatible. Biocompatibility is the ability of a material to perform with 
an appropriate host response in a specific application (Williams, 1999). The criteria 
for determining the biocompatibility of a material depend on its end use application. 
Consequently, a wide range of materials encompassing all the classical materials 
such as metals, ceramics, glasses, and polymers have been investigated as 
biomaterials. Among these, polymers form a versatile class ofbiomaterials that have 
been extensively investigated for medical and related applications. This can be 
attributed to the inherent flexibility in synthesising or modifying polymers matching 
the physical and mechanical properties of various tissues or organs of the body. 
One of the first attempts was the use of the biostable synthetic polymer 
poly(methyl methacrylate) (PMMA) as an artificial corneal substitute. Encouraged 
by initial successes, surgeons started using a variety of polymers for different 
applications such as blood contacting devices, hip joint replacements, and as 
intraocular lenses (Castner and Ratner, 2002). Even though the application of these 
polymeric materials significantly improved the advancement of modern health care, 
the long-term biocompatibility of many of these materials remained a serious 
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concern. During the latter half of the twentieth century, material scientists began 
attempts to engineer novel polymeric materials or modify existing polymers which 
could exhibit biocompatibility and adequate mechanical properties suitable for 
specific biomedical applications. fu addition, recent advances in biotechnology and 
pharmaceutical science opened novel frontiers in biomedical fields that demanded 
materials with bioactivity, biocompatibility, and in many cases transient existence. 
1.3 Skin template 
Human skin is an organ comprised of two horizontal tissues, the dermis 
overlaid with the epidermis. It covers the human body of an adult over a surface of 
1.7 m2 (Guerret et al., 2003). The major property of the epidermis, which is mainly 
composed of keratinocytes and melanocytes, is to protect the body from external 
insults. It is the first line of defence against infection, and it provides a barrier to 
pathogens in the environment. The underlying tissue, the dermis, has many fewer 
cellular components and consists of a dense arrangement of extracellular matrix 
components that provide a template for cells, vessels, and bioactive molecules. 
Other important roles of the skin include regulating body temperature and removal 
of body waste (Silver, 1994). 
The epidermis is composed of several layers called strata, and like all epithelial 
tissues, is a vascular. The main cell types of the epidermis are keratinocytes. These 
cells produce the fibrous protein keratin that provides the structural touglmess of the 
epidermis. The outermost layer, the stratum corneum, is 20 to 30 cell layers thick. It 
accounts for approximately three-quarters of the epidermal thickness. It is the 
abundance of keratin in the stratum corneum that protects the deeper viable cells 
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from biological, chemical and physical injury (Marcu et al., 2000). 
The dermis is strong, elastic and well supplied with blood vessels and nerves. 
Fibroblasts are the main cell type of the dermis and are responsible for maintenance · 
of the dermal extracellular matrix (ECM). Collagen (types 1 and III) and elastin are 
the proteins in the dermis; collagen provides toughness and binds water to keep the 
skin hydrated and elastin provides elasticity (Marcu et al., 2000). The dermis 
provides essential structural support and nutrients to the epidermis. Subcutaneous 
tissue lies underneath the dermis. It consists of loose connective tissue and adipose 
tissue. The adipose tissue serves as insulation and as an energy reserve. The 
subcutaneous layer also connects the dermis to the surface muscles. 
The mechanical properties of the skin are important to its function. Properties 
such as tear resistance, shear strength and tensile strength are all important for the 
proper functioning for the skin as a barrier. Tensile strength has been used 
extensively as a way to compare the mechanical properties of soft tissue and 
biomaterials (Berthod et al., 1994; Tomihata and Ikada, 1997; Thacharodi and Rao, 
1993). The tensile properties of full thickness skin have been studied by Yamada and 
Evans (1970). It was found that the tensile properties for the skin as a barrier vary 
with age, body location and case of gender. The average ultimate tensile strength of 
skin was reported as 6.3- 7 MPa, elongation at break was I 00%, and the elastic 
modulus was 35 MPa. These mechanical properties demonstrate that skin is a highly 
extensible material. Fibroblasts are connective tissue cells that play an integral part 
in dermal maintenance and the wound repair process. Fibroblasts located in the 
dermis are mainly responsible for the synthesis and secretion of ECM components 
such as collagen (Singer and Clark, 1999). 
Collagen plays a major role in the architecture of the skin; it represents 40-50% 
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of the dry weight of the skin, the bulk of which is made up of types I and III collagen. 
Recently, the importance of dermal fibroblasts for the maintenance of phenotype for 
keratinocytes was reported (Ghalbzouri et al., 2002). In their study, a decellularised 
dermis was seeded with keratinocytes in the absence and presence of dermal 
fibroblasts. Immuno histochemical techniques showed that the absence of fibroblasts, 
the epidermis formed consisted of only two to three viable cell layers with a very 
thin stratum corneum, however, in the presence of fibroblasts, keratinocyte 
proliferation and migration was stimulated and epidermal morphology markedly 
improved. The stimulatory effect of fibroblasts showed a biphasic response: 
keratinocyte proliferation increased the initial phase but decreased later stages of cell 
culture. 
1.4 Problem statement 
Different modification techniques provide good approaches to control the 
interactions between living systems and implanted materials by modifying the 
surface characteristics. The study of the interactions of biologically active species 
with materials is possible through the preparation of structures consisting of 
materials, cells and proteins that promote a specific biological response after 
implantation (Ratner et al., 2004; Hasirci et al., 1998). 
For many years, poly(dimethyl siloxane) (PDMS, commonly called silicone 
rubber) has been investigated as a biomaterial for the production of medical devices, 
such as artificial heart, breast implants, ophthalmologic devices, artificial noses, ears, 
and chins in maxillofacial reconstruction, and artificial skin (Y annas and Burke, 
1980; Lindeman, 1989; Bolz and Schaldach, 1993; Madou and Tierney, 1993). The 
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stability, toxicity, hydrophobicity, tissue response, and oxygen permeability of this 
material have been reported in many articles. Although silicone rubber has excellent 
bioinertness, softness, and stability, serious problems arise when silicone devices are 
implanted for a long time (Cifkova et al., 1990; Khorasani et al., 1996; Vladkova, 
2004). Because the body recognizes as foreign hydrophobic biomaterials such as 
silicone rubber, they stimulate inflammation and fibrosis, the latter process 
generating a fibrous capsule that isolates the biomaterial. Hydrogels (Okada and 
Ikada, 1993) and collagen (Kinoshita et al., 1993) coatings have been reported to 
reduce fibrosis around biomaterials implanted in animals. This approach for 
enhancing the surface properties of PDMS and their hydrophilicity and 
biocompatibility is through the incorporating ofhydrogels and collagen. 
PDMS is modified in order to enhance its hydrophilicity and wettability by 
poly(hydroxyethyl methacrylate) (PHEMA) and poly(acrylic acid) (PAA) hydrogels 
via interpenetrating polymer networks (IPNs) and blending methods to introduce a 
suitable functional group for coupling of collagen in outer layer of PDMS to 
enhance their biocompatibility. Several approaches based on surface and bulk 
modifications have been attempted for improving the surface properties of PDMS 
using hydrogels by laser, plasma, corona discharge and particulate composites 
methods. Interpenetrating polymerisation is the only way of combining cross-linked 
polymers. This technique can be used to combine two or more polymers into a 
mixture in which phase separation is not as extensive as it would be otherwise. These 
particular methods are advantageous because these are relatively simple, cost 
effective, and less time-consuming in comparison to other chemical and physical 
processes. 
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1.5 Research objectives 
In general, the most common polymers used in the medical field are 
hydrophobic. For this reason, the incorporation of functional groups onto polymer 
surfaces to improve their hydrophilicity, without changing the mechanical behavior 
of the material, is widely studied. Different modifications of biomaterials surfaces 
are normally used to increase the biocompatibility and the adhesion between 
different biomaterials. 
The aim of this work was the modification of PDMS films by hydrogel 
polymers of PHEMA and P AA via IPN and blending methods to create suitable 
functional groups for collagen grafting in outer layer of silicone to enhance their 
biocompatibility. Thus, incorporating of hydrogels and collagen onto PDMS 
surface may give the silicon substrates with new and interesting properties for 
applications in silicon-based implantable biomaterials. It is hypothesized that 
grafted collagen can modulate the foreign body response in vivo and lead to 
improved healing in the area surrounding an implanted material. 
The specific aims of this work were to: 
(1) To introduce specific functional groups onto PDMS for biomolecules binding 
and hydrophilicity improvement ofPDMS using hydrogels, 
(2) To improve biocompatibility ofPDMS using collagen, 
(3) To investigate and suggest the optimum conditions of hydrogels content in 
PDMS/ hydrogel IPNs, 
(4) To produce different PDMS based films using hydrogels and collagen as skin 
substitute, 
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(5) To evaluate the biocompatibility of different collagen grafted modified PDMS 
films by in vitro assay to determine their cytotoxicity and investigation of cell 
behavior. 
1.6 Outline of thesis structure 
This thesis is organized into five chapters: 
Chapter 1 commences with some basic information on the definition of biomaterials 
and skin composition followed by a brief introduction on the historical overview of 
uses polymers in the skin substitutes. Issues were of concern, which generated the 
ideas and inputs for this research work, are also elaborated upon. The primary 
objectives and the general flow of the research program are also outlined. 
Chapter 2 relates some background on engineering polymeric biomaterials for 
biomedical applications and classification of skin substitutes and bum dressing. 
Explications on the methods of the surface and bulk modification of PDMS with 
special focus on the interpenetrating polYmer network (IPN) method and applications 
of hydrogels and biopolymers are also provided. Subsequently, a literature review 
was done on various published works on silicone, hydrogels and collagen based 
biomaterials for biomedical applications particularly those that are closely related to 
this work. 
Chapter 3 details the experimental procedures employed in this research. 
Descriptions of lab equipments used as well as any other processing techniques 
utilised in generating any data that were used and presented· in the research are 
reported. 
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Chapter 4 is actually the results and discussion chapter according to the research 
objectives. The first part of this chapter describes the modification of PDMS via 
interpenetrating polymer networks by PHEMA and P AA hydro gels and subsequently 
their collagen grafted experiments. In addition, this part investigates the optimum 
condition of hydrogel content in silicon/hydrogel IPN. The second part of this 
chapter introduces the results and discussion of their blending method. 
Finally, in Chapter 5, presents some concluding remarks on the present work as well 
as some recommendations for future studies. 
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CHAPTER2 
LITERATURE REVIE\V 
2.1 Biomedical applications of polymers 
Polymers have physical properties that most closely resemble those of soft 
tissues and therefore this class of materials is used extensively to replace the 
functions of soft tissues including skin, tendons, cartilage, vessel walls, breast and 
bladder. A number of synthetic polymers find applications as biomaterials. They 
include polyolefins, polyamides, polyurethanes, polyacrylates, polysulfones, 
polyethers, and silicone rubbers (Fig. 2.1 ). Some of these materials are also used as 
sutures, tissue adhesives, shunts, catheters, and space fillers. Synthetic biomaterials 
have been evaluated and used for a wide range of medical applications. The ultimate 
aim in medicine, besides prevention, is the healing of diseases and repairing damage 
after injuries. The task of engineers, material scientists and physicists is to provide an 
optimal system for these applications (Ratner,et. al., 2004). 
From a practical point ofview, medical applications of polymers are divided 
into three broad categories: I) extracorporeal uses include catheters, tubing, and fluid 
lines; dialysis membranes, artificial kidney; ocular devices; wound dressings and 
artificial skin, 2) permanently implanted devices include sensory devices; 
cardiovascular devices; orthopaedic devices; dental devices, and 3) temporary 
implants include degradable sutures; implantable drug delivery systems; polymeric 
scaffolds for cell or tissue transplants; temporary vascular grafts and arterial stents; 
temporary small bone fixation devices. 
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Ear & ear parts ---t_ 
Facial prostheSis --4M~6----- Dentures 
E®phQgUS Tracheal tubes 
lungitv~r;r,: Hea¥1 & heart 
compooerits 
Heart pacemaker --l!-7tr-_,. 
Gastrointestinal 
segments 
Blood vessels 
Anger joints 
Knee joints 
Ear & ear parts: acrylic, polyethylene, silicone, poly(vinyt chloride) (PVC) 
Dentures: acrylic, ultrahigh molecular weight polyethylene (UHMWPE), epoxy 
Facial prosthesis: acrylic, PVC, polyurethane (PUR) 
Tracheal tubes: acrylic, silicone, nylon 
Heart & heart components: polyester, silicone, PVC 
Heart pacemaker: polyethylene, polyacetal 
Lung, kidney & liver parts: polyester, polyaldehyde, PVC 
Esophagus segments: polyethylene, polypropylene (PP), PVC 
Blood vessels: PVC, polyester 
Biodegradable sutures: PUR 
Gastrointestinal segments: silicones, PVC, nylon 
Finger joints: silicone, UHMWPE 
Bones & joints: acrylic, nylon, silicone, PUR, PP, UHMWPE 
Knee joints: polyethylene 
Figure 2.1 Types of polymers used in common biomedical applications (Ratner et al., 
2004) 
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Polymers can be used either as bioinert or bioactive materials, depending on 
the application. The medical devices that find either intra- or extracorporeal 
application hold a wide spectrum of synthetic materials such as polyethylene, 
polypropylene, polyvinylchloride, polyester, polystyrene, polyurethane, silicone, 
polysulphone, polyamide, polytetrafluoroethylene and their derivatives, that among 
them silicone is a widely used material due to its good biocompatibility and 
mechanical properties. Although these products have excellent physical properties, 
they were nonetheless developed primarily for industrial use and only lat~r found 
their way into biomedicine. Thus, all these synthetic materials display more or less 
the same disadvantage that is incompatibility with blood and tissues. Through 
contact with blood, this incompatibility can irritate a pathophysiological response 
from the organism, similar to that of traumatic shock. This extensive contact causes a 
massive activation of the cellular defence systems against the supposed attacker, and 
with that the human body boosts the various cascade reactions into motion. To avoid 
this drawback for example heparin-coating was recognized as an improvement on 
hemocompatibility of the materials used in biomedical applications. 
2.2 Classification of skin substitutes and wound dressing 
Skin is the largest organ of the human body and functions to protect the body 
from the external environment by maintaining temperature and haemostasis, as well 
as by performing immune surveillance and sensory detection. Skin consists of two 
main layers, an outer epidermis composed of stratified squamous epithelium and an 
inner dermis composed of dense connective tissue and fibroblasts. Significant skin 
loss due to injury or illness leading to damage of dermal or sub dermal tissues cannot 
heal properly and can lead to serious consequences (Sheridan and Tompkins, 1999). 
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Rapid healing of skin wounds is an important objective. The best way to heal 
a skin wound is to close it as fast as possible after injury according to surgical 
standards. However, this method is limited and often does not prove sufficient when 
the defect area is very large or the recipient microenvironment is poor. Such is the 
case in extensive skin bums, hard to heal chronic wounds and congenital skin 
disorders such as epidermolysis bullosa (EB). Over the years, advances in the field of 
tissue engineering have provided alternative methods to treat hard to heal skin 
wounds. These currently available products revolve around the in vitro fabrication of 
biomaterials that imitate natural skin anatomy and/or delivery of growth factors that 
encourage repair. However, these treatment strategies do not result in optimal healing, 
in part, due to an inability to fully restore the structure of the dermis. The best way to 
heal a wound is to close it surgically following injury. However, primary closure is 
not always possible in large-surface and deep wounds. In such cases it is necessary to 
replace as much of the missing tissue as possible (Ruszczak, 2003). 
Several types of wound dressings are commercially available to support 
wound healing processes. Sponges, hydrogels, woven and non-woven dressings 
derived from natural and abundant polymers have been developed for practical use. 
Historically, wound closure has been achieved via autologous skin grafting. However 
this method is not always feasible. In such cases, human allogenic skin can be used 
as a temporary matrix to manage the wound until autologous skin grafting is possible 
(Ruszczak and Schwartz, 2000). Alternatively, cadaver allograft matrices can be used 
to achieve temporary wound closure. Such matrices are prepared by removing the 
epidermal portion of the skin, leaving only the collagen rich dermal matrix. The 
dermal matrix is made non-viable before use in order to reduce its antigenicity and 
prevent host rejection. Autologous cultured epidermal sheets are then grafted on top 
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to enhance healing. Several banks are currently in operation in the world, providing 
cadaver skin to bum victims. Similarly, temporary wound coverage can be achieved 
via xenogenic dermal matrices, with porcine skin being the most common. However, 
sterility and immunogenic rejection is of greater concern with this treatment modality 
(Ruszczak, 2003). 
With the advancement of tissue engineering in the past decade, an array of 
products have been introduced for the treatment of hard to heal skin wounds and 
large defects, a number of which are currently available commercially. These tissue 
engineered skin substitutes are divided into those which utilize synthetic or 
biological based materials and those that incorporate skin derived cells. 
Acellular matrices can be subdivided into single layer and bilayer models. 
Single layer models include such products as CollatampFascie®, a bovine/equine 
collagen membrane and Promogran®, a spongy collagen matrix containing oxidized 
regenerated cellulose. Both these products are often used in conjunction with an 
epidermal allograft. CollatampFascie is used as a wound dressing or implant for 
healing of partial and full thickness chronic and acute wounds. Promogran has shown 
success in the treatment of chronic wounds. Namely, randomized clinical trials 
perfomied by Yin et al. (2002) and Veves et al. {2002) found that patients with 
venous and diabetic leg ulcers that were treated with Promogran experienced 
accelerate healing as compared with those treated with moistened gauze. It is 
hypothesized that the highly oxidized· regenerated cellulose concentration in this 
product acts as a substrate, reducing their activity and thus improving healing 
(Lohmann et al., 2005; Cullen et al., 2002). 
The bilayer models include such products as Integra® (Integra Life Science 
Corp) and Biobrane® (Bertek Pharmaceuticals). Integra is a bilayer membrane 
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composed of a dermal portion that consists of a porous lattice of fibers of cross-
linked bovine collagen and glycosaminoglycans ·(GAGs) and an epidermal layer 
consisting of a synthetic polysiloxane polymer (silicone) (Pham et al., 2007). The 
dermal layer functions as a biodegradable scaffold that allows for organized host 
dermal regeneration. The epidermal portion is later removed and replaced by an 
epidermal autograft. Integra is currently approved in for treatment· of partial and full 
thickness burns. 
Biobrane, currently in use, is synthetic dressing composed of a nylon mesh 
coated with polypeptides and bonded to a silicone membrane. Biobrane acts as a 
temporary covering of partial thickness dermal burns or meshed autografts and is 
trimmed away as the wound heals. In comparison to allografts, Biobrane 
demonstrated increased wound healing rates and pain reduction (Pham et al., 2007). 
The initial intent of designing biosynthetic skins was to provide a dermal 
substitute. However, the dermis is a structurally complex tissue, consisting of a 
variety of cell types, ECM molecules, skin appendages, blood vessels and nerves, 
none of which are supplied by these synthetic matrices. Thus these early tissue 
engineered matrices serve simply as bridging devices or imperfect templates for host 
tissue repair. As such, none of these products have been very successful in promoting 
and accelerating healing in chronic wound, large full thickness defects, and deep 
bums (Ruszczak, 2003). More recently these early biosynthetic skin substitutes as 
well as newer matrix designs have been used as delivery systems for skin derived 
keratinocytes and fibroblasts. These cells are thought to interact with the implant 
. matrix and the wound bed, producing growth factors and ECM component necessary 
for healing. There are currently several such products commercially available, 
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namely, TranCyte® (Smith &Nephew), Dermagraft® (Advanced Tissue Sciences) and 
Apligra~ (Organogenesis). 
TranCyte contains a silicone polymer membrane, seeded with newborn 
human keratinocytes, on a nylon mesh coated with porcine dermal collagen. This 
product has been approved for the treatment of full and partial thickness defects and 
bums. TranCyte is used only as a temporary wound covering and is removed once 
autografting is possible. Compared to traditional wound management methods, 
TranCyte was shown to decrease healing time and scar formation. 
Dermagraft, currently available in the world, is produced by seeding dermal 
fibroblasts from human foreskin onto a bioabsorable polyglactin mesh. The 
fibroblasts proliferate to fill the scaffold and secrete human collagen, matrix proteins, 
growth factors and cytokines to produce a neodermis containing living cells. 
Dermagraft has been designed to overcome the molecular deficiencies associated 
with chronic wounds by including exogenous growth factors into the polyglactin 
mesh. Dermagraft has been shown to be effective in promoting colonization of the 
wound bed, angiogenesis, fibroblast proliferation and matrix deposition and re-
epithelialization. In clinical trials, Dermagraft was effective in the healing and wound 
closure ofvenous ulcers and diabetic foot ulcers (Gentzkow et al., 1996). 
Apligraf, currently available in the world is commercialized form of living 
skin equivalent (Ruszczak and Schwartz, 2000). The construct contains two layers. 
The dermal layer is composed of a purified bovine type I collagen matrix mixed with 
human infant foreskin dermal fibroblasts which cause gel contractions and formation 
of a dense collagen lattice. The dermal portion is then seeded with human 
keratinocytes forming an epidermis-like structure. Apligrafhas shown success in the 
treatment of patients with EB, reducing wound healing time and improving quality of 
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life (Falabella et al., 2000). Apligraf has also been found to act as a natural substrate 
for proteases. As such, it is thought to be able to counteract the imbalance between 
matrix production and degradation in chronic wounds and therefore support wound 
re-epithelialization (Lohmann et al., 2005). 
Depending on the patient situation, optimal therapies need to be found for 
promoting wound closure and dermal regeneration. In the case of severely burned 
patients, skin has to be replaced rapidly and permanent coverage with split-thickness 
or cultured epithelial auto graft is required. However, patients may not have 
sufficient donor sites to cover their wounds if large areas are involved. In the case of 
chronic wounds attributed to an imbalance of healing factors, infection, reduced 
collagen deposition, and other cofactors, advanced therapies for treatment are needed. 
For all of these situations, skin substitutes have been shown to have moderate 
success and improvements on these substitutes holds great promise for wound 
healing strategies. Pressure ulcers, venous ulcers and burns are types of wounds that 
are most often treated with a dressing. Wound dressings are used to protect the site of 
injury from further insult, contamination and infections that may impede healing. 
Also, the benefit of a physiologically moist environment has been established (Bello 
and Phillips, 2000). 
Todays, there are many wound dressings available on the markets that 
address different kinds of wounds, treatments and phases in the wound healing 
process. Example, Comfeel®by Coloplast and Tegaderm®by 3M, hypercolloid and 
polyurethane dressings respectively are among the most appropriate for minimal to 
mild exudation (Bello and Phillips, 2000). Also, alginate dressings followed by 
hypercolloid dressings have shown best results for pressure ulcers. Dressings are 
fabricated from both synthetic and natural materials. They stated that there has been 
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no evidence that any dressing type enhances the healing rates of chronic diabetic 
ulcers. 
Over the past two decades extraordinary advances in cellular and molecular 
biology have led to a greatly improved understanding of the basic biological 
processes involved in wound repair and tissue regeneration. Ultimately, these great 
strides in basic knowledge will likely lead to advancements in wound care resulting 
in accelerated rates of ulcer and normal wound repair, scars of greater strength, and 
prevention of fibrosis. In addition, this information may translate into better design 
of artificial organs and tissue substitutes since the exposed surfaces of these materials 
should be designed so that they integrate completely and continuously with ~he 
surrounding tissues. 
Some tissue-engineered skin substitutes that are currently available are 
AHoDerm®, Integra®, Apligra~ (Graftskin) and Dermagraft®. Many of these 
products have had considerable success in trials, but have not overcome the main 
wound healing obstruction of tissue regeneration without wound contraction. Thus, 
tissue engineering skin products have not replaced skin grafting as the method of 
choice for clinical wound repair. Tissue-engineered skin refers to skin products made 
up from cells and extracellular matrix alone or in combination with growth factors. A 
variety of materials have been investigated as matrices including autologous, 
allogenic, and xenogenic tissues or synthetic and natural polymeric materials for skin 
tissue engineering. Three different approaches are currently in use to create artificial 
skin: to recreate the epidermis, to recreate the dermis, and to recreate both the dermis 
and epidermis using a bilayer graft. Thin layers of keratinocytes as such or cells 
cultured on polyurethanes (Epicel) and hyaluronic ester membranes (LASERSKIN) 
have been developed as epithelial replacements. Dermal substitutes make use of 
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biodegradable polymers such as collagen-glycosaminoglycan matrix covered 
with a silastic membrane as a barrier layer (Integra) as well as PLAGA (Vicryl) 
matrices seeded with human fibroblast cells (Dermagraft). A full-thickness graft has 
been developed using bovine collagen I matrices seeded with fibroblasts and 
keratinocytes called human skin equivalents (Apligraf). Multicenter clinical trials 
have revealed the accelerated healing capacity of chronic nonhealing venous stasis 
ulcers by the tissue-engineered graft. Figure 2.2 depicts some famous biological skin 
substitutes with their specifications. 
21 
(Dow HickarniBertek 
Phanneceuticafs, SUgar 
Land. TX). 
(Advanced TISSue 
Sciences, Inc. La Jolla, 
Ca&fomia. USA) 
(Adv8nced TISSUe 
Sciences, Inc. La Jolla. 
Catiromia, USA) 
(lnteg.alife ·Science 
Corporation, Plainsboro, 
New .Jersey) 
(UfeCeJI.WOOdlands, 
Texas.) 
(Genzyme tissue repair 
corporation, Cambridge, 
MA.) 
LaMraldti ... (Ficfta 
Advanced Biopolymer&, 
Italy) also madceted as 
VrvodeJmfM by ER Squibb & 
sons Inc. 
allograft (from 
not for profit skin banks) 
1. Acellular cf4t.. 
epllbeiJaliaed 
cadaver dennia 
1. Cultured autologous 
keratlnocyles 
2. Hyaluronic acid with 
...., 
• cryopreserved in 
order to retain 
viability 
• lyophlli8ed 
• glycarolleed 
Figure 2.2 Famous skin substitutes in the world (Jones et a1.,.2002). 
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2.3 The criteria for an ideal skin substitute 
Ideally a graft material should promote adequate wetting and draping, thus 
eliminating dead space, exhibit good adherence to the wound, prevent bacterial 
invasion, and control fluid loss. Further, the material should have adequate 
mechanical properties, promote endogenous cell infiltration, promote angiogenesis, 
and degrade with time. The use of biologically active matrices is now well accepted 
as accelerating wound healing and improving skin reconstruction. It is believed that 
cells encapsulated within the dermal matrix are able to produce ECM components 
that contribute to healing. In addition, these cells may interact with pre-existing host 
cell populations in the adjacent tissue resulting in cell migration into the wound bed. 
Despite these successes, there remains a need to stimulate the healing of acute 
and chronic wounds to a level that is presently not possible with standard methods of 
care or application of biosynthetic skins. As discussed above, current products 
demonstrate large variability in success rates depending in the wound type and 
patient history. In addition, even the best products currently available on the market 
have success rates below 60% for the treatment of hard to heal wounds. This limited 
success is mainly due to the inability of the skin substitutes to modulate an adequate 
matrix-wound cell interaction and integration and to promote wound vascularization 
necessary for graft take. The ideal skin substitute is inexpensive, long shelflife, used 
off the shelf, non-antigenic, durable, flexible, prevents water loss, barrier to bacteria, 
conforms to irregular wound surfaces and drapes well, easy to secure, applied in one 
operation, and does not become hypertrophic (Sheridan and Tompkins, 1999). 
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2.4 Applications of silicone based biomaterials 
Silicone is the generic name for entirely synthetic polymers cot~taining a 
repeating Si-0 backbone. The organic groups attached to the silicon atom via silicon-
carbon bonds define the class of silicone. The most common e"ample is 
poly( dimethyl siloxane) (PDMS) as shown in Fig. 2.3. 
Figure 2.3 The structure of poly( dimethyl siloxane) (PDMS) 
Poly(dimethyl siloxane) (PDMS) based elastomers have been used in a wide 
range of biomedical applications, as a result of their physiological inertness, good 
blood compatibility , low toxicity ,good thermal and oxidative stability, low modulus, 
anti adhesive properties and many desirable properties including low surface 
energies, high flexibility and low glass transition temperature. Since the end of 1950, 
silicone elastomer has been widely used for medical devices such as breast prosthesis, 
shunt valve for hydrocephalus, drainage implants in glaucoma, artificial skin, 
maxillofacial reconstruction, denture liners, pace maker lead insulator, contact lenses 
and catheter, membrane for oxygenator, heart valve and vascular grafts and 
numerous studies have been conducted on toxicity stability tissue response and 
oxygen permeability (Walter, 1968; Khorasani et al., 2005). 
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